Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Change in Account Payables: 2020-2025

Historic Change in Account Payables for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to $561,000.

  • Caribou Biosciences' Change in Account Payables rose 217.61% to $561,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 82.81%. This contributed to the annual value of -$354,000 for FY2024, which is 119.46% down from last year.
  • Caribou Biosciences' Change in Account Payables amounted to $561,000 in Q3 2025, which was up 189.05% from -$630,000 recorded in Q2 2025.
  • In the past 5 years, Caribou Biosciences' Change in Account Payables registered a high of $2.7 million during Q1 2024, and its lowest value of -$2.4 million during Q2 2024.
  • Its 3-year average for Change in Account Payables is $254,545, with a median of $540,000 in 2023.
  • Over the last 5 years, Caribou Biosciences' Change in Account Payables had its largest YoY gain of 640.44% in 2022, and its largest YoY loss of 5,275.68% in 2022.
  • Quarterly analysis of 5 years shows Caribou Biosciences' Change in Account Payables stood at $291,000 in 2021, then crashed by 152.58% to -$153,000 in 2022, then skyrocketed by 577.12% to $730,000 in 2023, then crashed by 131.37% to -$229,000 in 2024, then surged by 217.61% to $561,000 in 2025.
  • Its Change in Account Payables stands at $561,000 for Q3 2025, versus -$630,000 for Q2 2025 and $1.4 million for Q1 2025.